They observed cGAS immunoreactivity in fibrotic regions associated with fibroblasts in lung tissue of IPF patients, and provided evidence that cGAS reinforces lung fibroblast senescence involving damaged self-DNA, thus suggesting that targeting of cGAS to suppress senescent-like responses may have potential therapeutic implications in IPF. The gene discussed is CGAS; the disease is idiopathic pulmonary fibrosis.